XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Discontinued Operations
9 Months Ended
Sep. 30, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations
Note 2. Discontinued Operations
On April 1, 2024, 3M completed the separation of its Health Care business (the Separation) through a pro rata distribution of 80.1% of the outstanding shares of Solventum Corporation (Solventum) to 3M stockholders. As a result, Solventum became an independent public company, 3M no longer consolidates Solventum into 3M’s financial results and the historical net income of Solventum and applicable assets and liabilities included in the Separation are reported in 3M's consolidated financial statements as discontinued operations. Refer to Note 2 to the Consolidated Financial Statements in 3M's 2024 Annual Report on Form 10-K for more information regarding the Separation and the various agreements (supply, transition and other agreements) that provide for the relationship between 3M and Solventum.
3M continuing involvement with Solventum in the form of net sales under supply agreements and income from transition agreements is reflected in amounts disclosed in "Corporate and Other" in Note 19, recorded as net sales and associated costs and recorded as a direct offset to associated costs within selling, general and administrative expenses, respectively. Solventum transition agreement income for the three and nine and months ended September 30, 2025 was approximately $30 million and $120 million, respectively (approximately $0.2 billion and $0.6 billion gross fees, net of assigned costs, respectively). Solventum transition agreement income for the three and nine months ended September 30, 2024 was approximately $5 million and $40 million, respectively, (approximately $0.2 billion and $0.4 billion gross fees, net of assigned costs, respectively). Transition services or purchases from Solventum are not material to 3M. Amounts due from Solventum and amounts due to Solventum under the agreements referenced above were approximately $0.4 billion and $0.2 billion, respectively, as of September 30, 2025 and as of December 31, 2024.
Information regarding net income from discontinued operations, net of taxes includes the following:
Net income from discontinued operations, net of taxes (millions)
Nine months ended
September 30, 2024
Net sales
$1,987 
Cost of sales844 
Other operating expenses
837 
Other expense (income), net
44 
Income from discontinued operations before income taxes
262 
Provision for income taxes98 
Net income from discontinued operations, net of taxes
$164 
Cash flows related to discontinued operations have not been segregated, and are included in the Consolidated Statement of Cash Flows for all periods presented. Selected financial information related to cash flows from discontinued operations is below.
Selected cash flow information from discontinued operations (millions)
Nine months ended
September 30, 2024
Depreciation and amortization$139 
Purchases of PP&E
77